ERBB2 and breast cancer: Moreover, immunohistochemistry studies using breast cancer tissues show that DNAJA3/Tid1 levels are inversely correlated with tumor malignancy and ErbB2 levels through direct interaction with ErbB2 to promote CHIP-mediated proteasomal degradation [99].